You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Advances in Myeloma: Updates and Insights From the 2022 Summer Meetings

  • Authors: Caitlin Costello, MD; Nisha S. Joseph, MD; Amrita Krishnan, MD, FACP
  • CME / ABIM MOC Released: 8/5/2022
  • Valid for credit through: 8/5/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for hematologists/oncologists and other healthcare providers (HCPs) involved in the care of patients with multiple myeloma (MM).

The goal of this activity is that learners will be better able to understand data presented at the 2022 American Society of Clinical Oncology (ASCO®) Annual Meeting and European Hematology Association (EHA) 2022 Congress related to the management of MM, and to improve physician confidence with integrating these data into clinical practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • New clinical trial data in MM 
  • Demonstrate greater confidence in their ability to
    • Apply recent data in the field of MM to clinical practice


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


  • Caitlin Costello, MD

    Associate Clinical Professor of Medicine
    UC San Diego Health 
    UCSD/Sharp Healthcare Transplant Program
    Blood & Marrow Transplant Services 
    Moores Cancer Center
    La Jolla, California


    Caitlin Costello, MD, has the following relevant financial relationships: 
    Consultant or advisor for: Bristol Myers Squibb; Janssen; Pfizer; Takeda
    Research funding from: Bristol Myers Squibb; Janssen; Takeda

  • Nisha S. Joseph, MD

    Assistant Professor
    Department of Hematology and Medical Oncology
    Winship Cancer Institute
    Emory University
    Atlanta, Georgia


    The opinions expressed are those of Dr Joseph and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Joseph’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare. 

    Nisha S. Joseph, MD, has no relevant financial relationships.

  • Amrita Krishnan, MD, FACP

    Judy and Bernard Briskin Center for Multiple Myeloma Research
    Department of Hematology and Hematopoietic Cell Transplantation
    City of Hope Medical Center
    Duarte, California


    Amrita Krishnan, MD, FACP, has the following relevant financial relationships: 
    Consultant or advisor for: Adaptive; Artiva; Astra Zeneca; Bristol Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Regeneron; Sanofi
    Speaker or member of speakers bureau for: Amgen; Bristol Myers Squibb; GlaxoSmithKline; Takeda 
    Research funding from: Janssen 
    Stock options from: Bristol Myers Squibb
    Other: Scientific advisory board SUTRO


  • Megan Whitney, DMD

    Medical Education Director, Medscape, LLC  


    Megan Whitney, DMD, has no relevant financial relationships.  

Compliance Reviewer

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Advances in Myeloma: Updates and Insights From the 2022 Summer Meetings

Authors: Caitlin Costello, MD; Nisha S. Joseph, MD; Amrita Krishnan, MD, FACPFaculty and Disclosures

CME / ABIM MOC Released: 8/5/2022

Valid for credit through: 8/5/2023


Contents of This CME Activity

All sections of this activity are required for credit.

Frontline Myeloma Therapy

Dr Joseph discusses the rapidly evolving treatment strategies for newly diagnosed multiple myeloma.
Nisha Joseph, MD

Advances in CAR T Cell Therapy for Multiple Myeloma

Dr Costello reviews newer emerging CAR T cell therapies and provides updates on trial data.
Caitlin Costello, MD

Emerging Bispecific Therapies in Multiple Myeloma

Dr Krishnan provides timely updates on the emergence of bispecifics in the relapsed/refractory setting.
Amrita Krishnan, MD, FACP

Learning Feedback Questions

Before you begin, please take this brief survey.

  • Print